Michael andreeff (31 Ergebnisse)

Hardcover. Zustand: Very Good. Tight clean hardback, name on fly, not a library book.

Hardcover. Zustand: Good. No Jacket. 0897663314. Blue cloth hardcover, from closed pharmaceutical company library. 408 pages, index, illustrated with charts, tables and diagrams. Contents paper clip marks on front endpapers clean, tight and bright. Book.

Broschiert. Zustand: Gut. XV, 182 S. Das hier angebotene Buch stammt aus einer teilaufgelösten wissenschaftlichen Bibliothek und trägt die entsprechenden Kennzeichnungen (Rückenschild, Instituts-Stempel.). Schnitt und Einband sind etwas staubschmutzig; der Buchzustand ist ansonsten ordentlich und dem Alter entsprechend gut. Sprache: Deutsch Gewicht in Gramm: 400.…

Zustand: Near Fine. NY 1986. Annals of New York Academy of Science, Vol. 468. Octavo, original printed hardcover. A few institution stamps, but no spine numbers and no pocket. Near Fine.

VIII, 141 Seiten. 49 graphische Darstellungen und 56 Tabellen. Großoktav (24x16 cm) Orig.Karton. ** Gutes, sauberes Exemplar. Mit persönlicher Widmung des Autors J. Schumann.

Zustand: New.

Zustand: New.

Hardcover. Zustand: new. Hardcover. This book provides an unprecedented overview of "Targeted Therapies" for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make "leukemia history" in the near future. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Zustand: New.

Zustand: New.

Zustand: As New. Unread book in perfect condition.

Zustand: New. 1st edition NO-PA03JAN2015-KAP.

Zustand: As New. Unread book in perfect condition.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - How Do We Treat Hematology and Oncology have seen rapid progress and advances during recent years. Increased knowledge of tumor biology, epidemiology, molecular genetics, growth reg- lation, and cellular functions has led to novel therapeutic paradigms. Targeted trea- ment approaches, antibodies, immunotherapy, and other new techniques complement classic chemotherapy, radiotherapy, and surgery. Patients are increasingly well educated as web-based information on diagnostic and therapeutic options as well as quality ma- agement and tumor outcome data are readily available. In this dynamic and fast-paced environment, it is of central importance to base clinical decisions and medical practice on the best available evidence. Continuous quality ma- agement, with clinical process documentation, standardization, and evaluation, leads to improved patient care and long-term outcomes. For these reasons, we have started to systematically capture and evaluate data on diagnosis, treatment, and outcomes of p- tients with solid tumors and hematological neoplasms at the Freiburg University Med- cal Center. We have developed standard operating procedures, clinical pathways, and diagnostic and therapeutic processes, following the principles of 'Good Clinical Pra- tice.' Tese processes (e.g., detailed protocols for chemotherapy application, treatment fowcharts, clinical pathways) are continuously tested and validated in clinical practice.…

Zustand: New.

Hardcover. Zustand: Brand New. 1st edition. 826 pages. 9.25x6.25x2.00 inches. In Stock.

Hardcover. Zustand: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Hardcover. Zustand: Very Good. 1st Edition. Hardcover, 455 pages, 1999. First Edition . A Nearly Very Good copy. Book has moderate wear, crease or crimp to a few pages. Text appears clean.

Zustand: New.

Zustand: New.

Zustand: New.

Zustand: As New. Unread book in perfect condition.

Zustand: As New. Unread book in perfect condition.

Hardcover. Zustand: Good. Good. Dust Jacket NOT present. CD WILL BE MISSING. . SHIPS FROM MULTIPLE LOCATIONS. book.

Zustand: new. Questo è un articolo print on demand.

Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book provides an unprecedented overview of 'Targeted Therapies' for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make 'leukemia history' in the near future. 848 pp. Englisch.…

Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This book provides an unprecedented overview of 'Targeted Therapies' for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make 'leukemia history' in the near future.…

Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Focused on practice with special emphasis on standardizing chemotherapy protocolsPractice-relevant information on supportive treatment measuresFlow charts on therapy planningPrecise information on how to proceed in emergency situatio.…

Buch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book provides an unprecedented overview of 'Targeted Therapies' for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make 'leukemia history' in the near future.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 848 pp. Englisch.…

Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -A real boon for medical practitioners from a number of disciplines, this is a practice-oriented manual of medical oncology and hematology for day-to-day use in caring for patients' hematologic and neoplastic diseases. It is founded on the longstanding experience of a large specialized university department accustomed to having to provide reliable advice in a broad range of circumstances. The authors have chosen not to give a comprehensive review of the various subjects but have instead focused on practical methods which have proven to be useful in their experience, with special emphasis on standardizing chemotherapy protocols. 1002 pp. Englisch.…